• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    EnWave Signs Technology Evaluation and License Option Agreement with Calbee Incorporated

    Jocelyn Aspa
    Jan. 10, 2018 08:53AM PST
    Pharmaceutical Investing

    EnWave (TSXV:ENW) has announced that it has signed a technology evaluation and license option agreement with Calbee, a snack food manufacturer in Japan. As quoted in the press release: After multiple site visits and extensive preliminary trials at EnWave’s facilities in Canada, Calbee decided to enter a TELOA to exclusively evaluate several snack food applications …

    EnWave (TSXV:ENW) has announced that it has signed a technology evaluation and license option agreement with Calbee, a snack food manufacturer in Japan.
    As quoted in the press release:

    After multiple site visits and extensive preliminary trials at EnWave’s facilities in Canada, Calbee decided to enter a TELOA to exclusively evaluate several snack food applications at their facilities using lab-scale Radiant Energy Vacuum (“REV™”) technology.
    This is the first TELOA signed by EnWave with a Japanese food manufacturing company and represents an important milestone for the Company. Over the past year, EnWave has been working under a Cooperation Agreement with Correns Corporation (“Correns”) of Tokyo to broaden its sales and business development network in Japan. Correns will continue to collaborate with EnWave to support both research and development, as well as potential future commercial installations in Japan.

    Click here to read the full press release.

    pharmaceutical investingcanadabusiness development
    The Conversation (0)

    Go Deeper

    AI Powered
    Medical pills branded with Canadian flag.

    Canadian Pharma Stocks: 5 Biggest Companies

    Phrase "top technology stocks" on blue background.

    Top 5 Technology Stocks on the TSX Venture 50

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×